NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-028-2015-1-EP-05 Anti-Mutated Kras T Cell Receptors EP National Stage 15807756.0 Issued
NICHD E-008-2015-0-PCT-02 Joint Probability Distribution Determinations for Material Assessments PCT PCT PCT/US2015/062489 Expired
NCATS E-214-2014-1-PCT-01 Small Molecule Aldehyde Dehydrogenase Inhibitors And Methods Of Use Thereof PCT PCT COMB PCT/US2015/062467 Expired
NCI E-213-2014-0-EP-01 Methodology For Astatination And Radioiodination Based On Iodonium Salt Precursors EP ORD 15306862.2 Abandoned
NCI E-028-2015-1-PCT-01 Anti-Mutated Kras T Cell Receptors PCT PCT COMB PCT/US15/062269 Expired
NCI E-028-2015-1-CA-03 Anti-Mutated Kras T Cell Receptors CA National Stage 2968399 Pending
NIAID E-067-2016-1-US-01 A Novel Method Of Vaccination With An Attenuated RSV Vaccine Formulation US 62/259,472 Abandoned
NINR E-349-2013-2-US-02 Detection and Treatment of Irritable Bowel Syndrome US National Stage 14/892,999 9683263 Issued PDF
NCI E-010-2016-1-US-01 Anti-BCMA Polypeptides and Proteins US 62/257,493 Abandoned
NIAID E-045-2015-0-EP-03 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use EP National Stage 15797815.6 Issued
NIAID E-045-2015-0-CH-12 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use CH EP 15797815.6 Issued
NIAID E-045-2015-0-GB-09 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use GB EP 15797815.6 Issued
NIAID E-045-2015-0-FR-08 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use FR EP 15797815.6 Issued
NIAID E-045-2015-0-IT-10 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use IT EP 15797815.6 Issued
NIAID E-045-2015-0-DE-07 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use DE EP 15797815.6 Issued
NCI E-093-2013-2-US-08 Compounds for Inhibiting Drug-Resistant Strains of HIV-1 Integrase US National Stage 14/891,309 9676771 Issued PDF
NIAID E-278-2016-0-PCT-02 Antibodies That Neutralize Ebola Virus And Uses Thereof PCT PCT PCT/IB2015/002342 Expired
NCI E-186-2015-0-PCT-01 Peptide and Peptide Mimetic Binding Antagonists of Polo-Like Kinase 1 Polo Box Domain and Methods of Use PCT PCT PCT/US2015/060629 Expired
NIAID E-045-2015-0-PCT-02 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use PCT PCT PCT/US2015/060733 Expired
NHLBI E-036-2015-1-PCT-01 NK Cells with an Increased Antibody-Dependent Cellular Toxicity (ADCC) Against Tumors PCT PCT COMB PCT/US2015/060646 Expired
NIDDK E-034-2015-0-PCT-02 Device and System for Manipulating Small Model Organisms PCT PCT PCT/US2015/060575 Expired
NIAID E-045-2015-0-EP-06 Neutralizing Antibodies to Ebola Virus Glycoprotein and Their Use EP DIV 21158309.1 Pending
NIDDK E-034-2015-0-EP-04 Device and System for Manipulating Small Model Organisms EP National Stage 15805014.6 Abandoned
NIDDK E-034-2015-0-CN-03 Device and System for Manipulating Small Model Organisms CN National Stage 201580073355.6 Abandoned
NCI E-010-2016-0-US-01 Anti-BCMA Polypeptides and Conjugates US 62/255,255 Abandoned
NCI E-139-2015-0-US-01 Fixatives and Methods of Use US 62/255,030 Abandoned
NCI E-226-2014-0-CA-04 Anti-Human Thyroglobulin T Cell Receptors CA National Stage 2967778 Issued
NICHD E-039-2016-1-EP-05 Treatment of Hormonal Disorders of Growth EP National Stage 15798305.7 Issued
NICHD E-039-2016-1-DE-08 Treatment of Hormonal Disorders of Growth DE EP 15798305.7 Issued
NICHD E-039-2016-1-FR-09 Treatment of Hormonal Disorders of Growth FR EP 15798305.7 Issued
NICHD E-039-2016-1-GB-10 Treatment of Hormonal Disorders of Growth GB EP 15798305.7 Issued
NCI E-226-2014-0-AU-03 ANTI-THYROGLOBULIN T CELL RECEPTORS AU National Stage 2015346350 Issued
NCI E-226-2014-0-GB-12 Anti-Human Thyroglobulin T Cell Receptors GB EP 15801054.6 Issued
NCI E-226-2014-0-DE-11 Anti-Human Thyroglobulin T Cell Receptors DE EP 15801054.6 Issued
NCI E-226-2014-0-FR-10 Anti-Human Thyroglobulin T Cell Receptors FR EP 15801054.6 Issued
NCI E-226-2014-0-EP-05 Anti-Human Thyroglobulin T Cell Receptors EP National Stage 15801054.6 Issued
NCI E-226-2014-0-JP-06 Anti-Human Thyroglobulin T Cell Receptors JP National Stage 2017-525625 Issued
NICHD E-039-2016-1-PCT-01 Treatment of Hormonal Disorders of Growth PCT PCT COMB PCT/US2015/060442 Expired
NCI E-054-2013-2-HK-11 IL-15R ALPHA FORMS, CELLS EXPRESSING IL-15R ALPHA FORMS, AND THERAPEUTIC USES OF IL-15R ALPHA AND IL-15/IL-15R ALPHA COMPLEXES HK National Stage 15112238.0 Pending
NCI E-226-2014-0-PCT-02 Anti-Human Thyroglobulin T Cell Receptors PCT PCT PCT/US15/060282 Expired
NICHD E-039-2016-1-CA-04 Treatment of Hormonal Disorders of Growth CA National Stage 2965696 Pending
NCI E-033-2013-1-CN-02 Stabilized Single Human CD4 Domains And Fusion Proteins CN National Stage 201480026873.8 Issued
CC E-149-2014-0-DE-05 Topical Sodium Nitrite Formulation DE EP 15798623.3 Issued
CC E-149-2014-0-FR-06 Topical Sodium Nitrite Formulation FR EP 15798623.3 Issued
CC E-149-2014-0-EP-03 Topical Sodium Nitrite Formulation EP National Stage 15798623.3 Issued
CC E-149-2014-0-IE-07 Topical Sodium Nitrite Formulation IE EP 15798623.3 Issued
CC E-149-2014-0-GB-08 Topical Sodium Nitrite Formulation GB EP 15798623.3 Issued
CC E-149-2014-0-PCT-02 Topical Sodium Nitrite Formulation PCT PCT PCT/US2015/060015 Expired
NIDCR E-033-2004-0-US-13 Multipotent Postnatal Stem Cells From Human Periodontal Ligament and Uses Thereof US CON 14/936,529 10046012 Issued PDF
NIAID E-152-2015-2-PCT-01 Probiotic Therapeutic Applications PCT PCT COMB PCT/US2015/059662 Expired